✦ LIBER ✦

Changes in the characteristics of patients prescribed selective cyclooxygenase 2 inhibitors after the 2004 withdrawal of rofecoxib

✍ Scribed by Setakis, E. ;Leufkens, H. G. M. ;van Staa, T. P.

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 87 KB
Volume: 59
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.23925

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rofecoxib, a specific inhibitor of cyclo

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

✍ Grant W. Cannon; Jacques R. Caldwell; Peter Holt; Barry McLean; Beth Seidenberg; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views